Exploration disposals and impairment
The A$11.993m closing exploration balance reflected A$4.975m incurred, Lachlan Fold Belt and Clermont sales, and A$3.713m impairment.
Impact Minerals remained an exploration-stage consolidated group over FY2021–FY2025. The saved annual-extraction record shows small operating-income lines, recurring cash deployment, equity funding and material project-accounting movements; it does not establish mine production or recurring mining revenue.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Cash and cash equivalents at 30 June 2025.
Reported Group net assets.
Loss before tax from continuing operations.
Gross share proceeds before issue costs.
Impact reports mineral exploration as its principal activity. This review consequently centres on Group cash, funding, statutory loss and exploration accounting, rather than recasting interest, rebates or other income as mine revenue.
The consolidated position ends with reported Group net assets of A$11.412m and cash of A$2.451m at 30 June 2025. The A$12.189m FY2025 total-assets display is transparently calculated from these net assets and total liabilities rather than copied from parent-only records.
FY2025 includes distinct A$5.561m exploration impairment, A$0.157m expensed exploration and A$1.189m held-for-sale impairment lines; they are retained as different accounting measures.
The A$11.993m closing exploration balance reflected A$4.975m incurred, Lachlan Fold Belt and Clermont sales, and A$3.713m impairment.
Blackridge and 75% Commonwealth project sales sit beside A$3.939m expenditure incurred and A$1.122m impairment.
Operating cash flow was A$0.141m positive, with saved detail showing other income and R&D rebate receipts offset by supplier-and-employee payments.
The bridge includes Lake Hope acquisition costs and project impairment; the profit-and-loss statement separately records A$1.091m held-for-sale impairment.
A rights issue raised A$5.149m before costs. Project impairments and held-for-sale impairment are reported separately; later Commonwealth sale/JV developments are not backfilled into FY2025 statements.
Consolidated cash rose through FY2023 then declined to A$3.422m in FY2024 and A$2.451m in FY2025. Financing inflows remained positive in both years but did not offset combined operating and investing outflows; this is a historical cash-flow observation, not a funding forecast.
Exploration and evaluation carrying value was A$7.360m at FY2025. It remains distinct from annual exploration cash payments and resource estimates because it is affected by expenditure, asset movements and impairment under the accounts.
A$ million
AI-generated presentation · values from Consolidated financial position at each 30 June; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Consolidated financial position at each 30 June; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 3.416 | 3.816 | 4.689 | 3.422 | 2.451 |
| Exploration and evaluation asset carrying value | 11.993 | 11.195 | 9.568 | 9.814 | 7.360 |
| Assets held for sale | 0.115 | 3.483 | 3.278 | 1.782 | N/D |
| Total assets (FY2025 calculated: net assets + liabilities) | 16.023 | 19.201 | 18.471 | 15.886 | 12.189 |
| Total liabilities | 0.390 | 0.644 | 1.054 | 0.901 | 0.778 |
| Net assets / total equity | 15.633 | 18.557 | 17.417 | 14.985 | 11.412 |
A$ million. FY2021–FY2024 use consolidated Group statements, not the parent-entity summaries also preserved in the packet.
FY2025 total assets is calculated: reported Group net assets A$11.412m + reported Group liabilities A$0.778m = A$12.189m. It is not presented as a reported total-assets line.
No selected like-for-like FY2025 assets-held-for-sale balance is available; it is not treated as zero.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The Group reported a continuing-operations loss before tax in every displayed year. Exploration impairment was material but the loss also reflects other income, corporate costs, employee costs and other expenses, so this review does not create an adjusted earnings series.
FY2025’s A$5.718m non-cash exploration write-off add-back belongs to the operating-cash reconciliation. It is A$0.157m expensed exploration plus A$5.561m exploration impairment, not an additional impairment; the A$1.189m held-for-sale charge remains separate.
A$ million
AI-generated presentation · values from Reported income, costs and impairment charges; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue from operating activities | 0.016 | 0.004 | 0.076 | 0.116 | 0.079 |
| Other income | 0.140 | 0.444 | 1.477 | 0.445 | 0.547 |
| Corporate and administration expense | (0.718) | (0.751) | (1.006) | (1.517) | (1.509) |
| Employee benefits expense | (0.383) | (0.886) | (0.775) | (0.720) | (0.918) |
| Exploration expenditure expensed | N/D | N/D | N/D | 0.000 | (0.157) |
| Impairment of exploration expenditure | (3.713) | (1.122) | (5.473) | (3.803) | (5.561) |
| Impairment of assets held for sale | N/D | N/D | N/D | (1.091) | (1.189) |
| Loss before tax from continuing operations | (4.760) | (2.399) | (5.782) | (6.753) | (9.018) |
A$ million; negatives are reported expenses or losses. The small revenue/other-income lines are not mining sales or production revenue.
The FY2025 A$5.718m non-cash reconciliation add-back is not charted as an impairment: it comprises A$0.157m expensed exploration and A$5.561m exploration impairment.
Assets-held-for-sale impairment is separate from exploration impairment. FY2024 has a saved-source conflict: its direct P&L row reports A$1.091m, while FY2025 comparative disclosures state nil; the direct row is displayed and the conflict is retained as a limitation.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Net operating cash was negative in FY2021, FY2022, FY2024 and FY2025; FY2023 is the sole positive year. The saved detail makes clear that this is not evidence of recurring mining income: other-income and R&D-rebate receipts were central to the reported operating cash composition.
Net investing cash flow is retained beside exploration cash payments because acquisitions and disposals can change its direction and size. Gross share proceeds, issue costs and net financing are also separate reported cash-flow lines, rather than a synthetic funding calculation.
A$ million
AI-generated presentation · values from Statutory cash-flow lanes and funding; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Statutory cash-flow lanes and funding; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash from/(used in) operating activities | (0.818) | (0.739) | 0.141 | (1.402) | (1.379) |
| Payments for exploration activities | (4.841) | (3.486) | (3.252) | (3.325) | (2.956) |
| Net cash used in investing activities | (4.971) | (3.550) | (3.224) | (3.336) | (4.161) |
| Proceeds from issue of shares | 7.245 | 5.200 | 4.000 | 3.000 | 5.149 |
| Share issue costs | (0.472) | (0.510) | (0.044) | (0.208) | (0.536) |
| Net cash from financing activities | 6.773 | 4.690 | 3.956 | 3.471 | 4.569 |
| Net increase/(decrease) in cash | 0.984 | 0.400 | 0.873 | (1.267) | (0.971) |
A$ million; consolidated statutory cash-flow lines. Exploration payments are a component of investing activities, not a substitute for the net investing subtotal.
FY2023 operating cash flow was positive A$0.141m because saved cash-flow inputs include other income and an R&D rebate alongside supplier-and-employee payments; it does not establish recurring mine sales.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
This bridge is an accounting carrying-value reconciliation. FY2022 includes Blackridge and Commonwealth sales; FY2023–FY2024 identify project-specific impairment and acquisition movements. These are not annual cash-spend measures.
FY2025 records A$2.833m expenditure incurred and a A$7.360m closing balance, with individual impairment lines for Arkun, Commonwealth, Broken Hill, Doonia and other projects. A separate A$0.205m Commonwealth fair-value reduction and post-balance-date sale/JV developments are not added to FY2025 statement rows.
A$ million
AI-generated presentation · values from Exploration and evaluation asset bridge; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Opening carrying balance | 10.946 | 11.993 | 11.195 | 9.568 | 9.814 |
| Exploration expenditure incurred during year | 4.975 | 3.939 | 3.641 | 3.383 | 2.833 |
| Closing carrying balance | 11.993 | 11.195 | 9.568 | 9.814 | 7.360 |
A$ million; accounting carrying-value bridge, not a cash-flow, Mineral Resource or valuation table.
Movements include project disposals, acquisitions and impairment, so incurred expenditure, carrying value, impairment and exploration cash payments remain separate measures.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.